A new genetic study reveals that the protein NPM1 fuels the growth of bowel and some liver cancers, pointing to a promising target for more precise and less harmful cancer treatments.
A new genetic study reveals that the protein NPM1 fuels the growth of bowel and some liver cancers, pointing to a promising target for more precise and less harmful cancer treatments.
